(S)-cEt / Nucleoside Intermediates
DMT-protected (S)-cEt-G free-hydroxyl precursor
Quick view. A DMT-protected, N2-isobutyryl (S)-cEt guanosine precursor with a free hydroxyl group, identified by CAS 945628-65-9. Catalog target purity: Specification by inquiry. Availability: Inquiry only — contact OROGO to confirm current availability.
Request a quote Review request checklist
Catalog status
Scope. "Available for inquiry" is not a stock claim. Operating tier is a catalog-merchandising priority. Development phase and program context are shown only where the reviewed catalog source provides a mapping; they describe the chemistry platform and do not claim that OROGO supplies the named program.
| Supply status | Available for inquiry |
|---|---|
| Operating tier | Priority |
| Reviewed supporting program count | 2 |
| Representative chemistry-platform program | opemalirsen |
| Highest development phase | Phase II |
| CAS status | Published registry number |
Product profile
DMT-protected (S)-cEt-G free-hydroxyl precursor is classified as (s)-cet / nucleoside intermediates (Formula C37H39N5O8; molecular weight 681.70).
DMT-protected (S)-cEt-G free-hydroxyl precursor is associated with guanine-containing building blocks or substrates for G-position incorporation and analytical comparison.
For DMT-protected (S)-cEt-G free-hydroxyl precursor, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- N-[9-[(1R,3R,4R,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
Useful catalog search terms
- 945628-65-9
- IBDQCNVRHGCMBR-QXHHNENGSA-N
Physicochemical data
| IUPAC name | N-[9-[(1R,3R,4R,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide |
|---|---|
| InChIKey | IBDQCNVRHGCMBR-QXHHNENGSA-N |
| SMILES | CC1[C@]2([C@H]([C@@H](O1)[C@@H](O2)N3C=NC4=C3N=C(NC4=O)NC(=O)C(C)C)O)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
DMT-protected (S)-cEt-A free-hydroxyl precursor
Intermediates · CAS: 1197033-18-3
OR-INTE-0112DMT-protected (S)-cEt-5-Me-U free-hydroxyl precursor
Intermediates · CAS: 1197033-21-8
OR-INTE-0113DMT-protected (S)-cEt-5-Me-C free-hydroxyl precursor
Intermediates · CAS: 1197033-15-0
OR-LP-0041Maleimide NHS Ester (SMCC)
Intermediates · CAS: 64987-85-5
OR-LP-00633'-Cholesteryl-TEG CPG
Intermediates · CAS: N/A
OR-INTE-01097'-OH-O6-[2-(4-Nitrophenyl)ethyl]-N2-isobutyryl-N-trityl morpholino guanosine
Intermediates · CAS: N/A
Product-relevant literature
The publications below discuss named chemistry or a structural feature represented by this product. They provide scientific context only and are not an OROGO lot specification or product-performance claim.